Company / Depreciation & Amortization
Avidity Biosciences, Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$4.2M
FY2025
5-year range
$639.0K / $4.2M
FY2021-FY2025
Trend
+49.5%
vs FY2024
Sector context
#81 of 168
Health Care
What the data says
At $4M, Avidity Biosciences, Inc.'s depreciation & amortization ranks #88 of 168 in the Health Care sector. Depreciation & Amortization has increased for 6 consecutive years, from $348,000 in FY2019 to $4M in FY2025.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of +61.9%.
Increased from $2M to $4M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +44.1%
- 5-Year CAGR
- +61.9%
- 10-Year CAGR
- -
Sector benchmark
#88 of 168 in Health CareTop 52% of 168This company $4.2M Sector average $212.9M
▼
-98.1% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s depreciation & amortization has grown for 6 consecutive years.
- 5-year CAGR of +61.9%, indicating consistent growth.
- In FY2025, depreciation & amortization increased 49.5% year-over-year.
- Ranks #81 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.2M | +49.5% |
| FY2024 | $2.8M | +32.1% |
| FY2023 | $2.1M | +51.5% |
| FY2022 | $1.4M | +117.1% |
| FY2021 | $639.0K | +71.3% |
| FY2020 | $373.0K | +7.2% |
| FY2019 | $348.0K | -9.1% |
| FY2018 | $383.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026